Immunocore Holdings plc
IMCR
$33.98
-$0.50-1.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 115.93M | 106.68M | 104.48M | 103.69M | 97.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 115.93M | 106.68M | 104.48M | 103.69M | 97.96M |
| Cost of Revenue | 75.03M | 434.00K | 81.52M | 71.09M | 70.05M |
| Gross Profit | 40.89M | 106.24M | 22.95M | 32.61M | 27.92M |
| SG&A Expenses | 43.89M | 37.85M | 42.65M | 39.78M | 42.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -19.73M | -- | -- |
| Total Operating Expenses | 118.92M | 99.40M | 104.44M | 110.86M | 112.84M |
| Operating Income | -3.00M | 7.28M | 37.00K | -7.17M | -14.88M |
| Income Before Tax | -514.00K | 13.27M | -15.79M | 304.00K | -9.69M |
| Income Tax Expenses | 294.00K | 301.00K | 14.27M | 481.00K | 606.00K |
| Earnings from Continuing Operations | -808.00K | 12.97M | -30.06M | -177.00K | -10.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -808.00K | 12.97M | -30.06M | -177.00K | -10.30M |
| EBIT | -3.00M | 7.28M | 37.00K | -7.17M | -14.88M |
| EBITDA | -1.97M | 8.23M | 871.00K | -6.37M | -14.10M |
| EPS Basic | -0.02 | 0.26 | -0.60 | 0.00 | -0.20 |
| Normalized Basic EPS | -0.04 | 0.14 | -0.20 | 0.00 | -0.18 |
| EPS Diluted | -0.02 | 0.25 | -0.60 | 0.00 | -0.20 |
| Normalized Diluted EPS | -0.04 | 0.14 | -0.20 | 0.00 | -0.18 |
| Average Basic Shares Outstanding | 50.97M | 50.75M | 50.47M | 50.40M | 50.29M |
| Average Diluted Shares Outstanding | 50.97M | 52.93M | 50.47M | 50.40M | 50.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |